Total Payments
$5,376
2024 Payments
$125.46
Companies
27
Transactions
364
Medicare Patients
1,764
Medicare Billing
$139,662
Payment Breakdown by Category
Food & Beverage$5,376 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,376 | 364 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,822 | 149 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $563.98 | 19 | $0 (2024) |
| Novo Nordisk Inc | $458.93 | 27 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $290.27 | 21 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $240.87 | 13 | $0 (2024) |
| GlaxoSmithKline, LLC. | $228.87 | 14 | $0 (2023) |
| PFIZER INC. | $227.74 | 23 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $225.97 | 13 | $0 (2023) |
| Amgen Inc. | $208.20 | 16 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $157.89 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.46 | 5 | AstraZeneca Pharmaceuticals LP ($75.44) |
| 2023 | $2,133 | 140 | ABBVIE INC. ($485.40) |
| 2022 | $2,019 | 129 | ABBVIE INC. ($626.99) |
| 2021 | $1,098 | 90 | AbbVie Inc. ($709.85) |
All Payment Transactions
364 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $58.56 | General |
| Category: Respiratory | ||||||
| 01/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Biological | ||||||
| 01/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: NEUROSCIENCE | ||||||
| 12/29/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Respiratory | ||||||
| 12/14/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Diabetes | ||||||
| 12/07/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/05/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: PSYCHIATRY | ||||||
| 11/30/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Oncology | ||||||
| 11/21/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: PAIN | ||||||
| 11/14/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Diabetes | ||||||
| 11/09/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Obesity | ||||||
| 11/09/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Diabetes | ||||||
| 11/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Respiratory | ||||||
| 11/06/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 651 | 918 | $106,461 | $61,739 |
| 2022 | 10 | 589 | 734 | $75,664 | $41,094 |
| 2021 | 7 | 367 | 474 | $55,868 | $29,452 |
| 2020 | 5 | 157 | 170 | $16,312 | $7,376 |
Total Patients
1,764
Total Services
2,296
Medicare Billing
$139,662
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 246 | 495 | $61,380 | $31,847 | 51.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 152 | 152 | $24,320 | $15,676 | 64.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 22 | 22 | $6,600 | $6,190 | 93.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 60 | $6,360 | $2,859 | 45.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $3,995 | $2,242 | 56.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 38 | $1,140 | $1,088 | 95.4% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 34 | 34 | $850.00 | $744.60 | 87.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $720.00 | $687.12 | 95.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 25 | 30 | $600.00 | $285.60 | 47.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 26 | 32 | $160.00 | $70.40 | 44.0% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 14 | 14 | $336.00 | $49.94 | 14.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 184 | 270 | $33,480 | $17,785 | 53.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 107 | 107 | $17,120 | $11,122 | 65.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 145 | 192 | $20,352 | $8,096 | 39.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 13 | 13 | $1,399 | $1,376 | 98.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 35 | 35 | $1,040 | $949.91 | 91.3% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 23 | 23 | $828.00 | $727.49 | 87.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $515.00 | $489.91 | 95.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 12 | 12 | $300.00 | $253.08 | 84.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 16 | 21 | $420.00 | $201.05 | 47.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 35 | 42 | $210.00 | $93.23 | 44.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 145 | 225 | $27,870 | $14,547 | 52.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 62 | 62 | $9,920 | $6,616 | 66.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 96 | 118 | $12,508 | $5,441 | 43.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 13 | 13 | $3,055 | $1,766 | 57.8% |
About Allison Beavers, APRN
Allison Beavers, APRN is a Family healthcare provider based in Jeffersonville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2017. The National Provider Identifier (NPI) number assigned to this provider is 1114457835.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Allison Beavers, APRN has received a total of $5,376 in payments from pharmaceutical and medical device companies, with $125.46 received in 2024. These payments were reported across 364 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($5,376).
As a Medicare-enrolled provider, Beavers has provided services to 1,764 Medicare beneficiaries, totaling 2,296 services with total Medicare billing of $139,662. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Jeffersonville, IN
- Active Since 06/14/2017
- Last Updated 02/23/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1114457835
Products in Payments
- VRAYLAR (Drug) $1,015
- UBRELVY (Drug) $480.29
- NURTEC ODT (Drug) $375.65
- QULIPTA (Drug) $326.94
- FARXIGA (Drug) $261.33
- BREZTRI (Drug) $244.09
- TRINTELLIX (Drug) $240.87
- TRELEGY ELLIPTA (Drug) $213.82
- Rybelsus (Drug) $190.38
- SPRAVATO (Drug) $142.12
- ENTRESTO (Drug) $129.26
- Ozempic (Drug) $126.03
- COMIRNATY (Biological) $124.42
- XIFAXAN (Drug) $123.23
- CAPLYTA (Drug) $102.32
- Aimovig (Biological) $99.77
- Kerendia (Drug) $89.25
- Cologuard Collection Kit (Device) $87.96
- XARELTO (Drug) $83.85
- QUVIVIQ (Drug) $82.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Jeffersonville
Stacy Garcia, Aprn, APRN
Family — Payments: $13,689
Family $13,689
Michelle Vissing, Aprn, APRN
Family — Payments: $13,115
Family $13,115
Ms. Karona Yarbrough, Fnp-C, FNP-C
Family — Payments: $6,070
Family $6,070
Amanda Davis-Houchen, Fnp-C, FNP-C
Family — Payments: $4,422
Family $4,422
Aimee Knott, Fnp, FNP
Family — Payments: $4,167
Family $4,167
Ms. Sabina Sisic, Aprn, APRN
Family — Payments: $4,106
Family $4,106